Drug Discovery Market Research Reports & Industry Analysis
Drug discovery is the systematic process of identifying, designing, and developing new pharmaceutical compounds or therapies to treat specific diseases or medical conditions. This is a high-cost, risky business because only a fraction of the therapeutic targets selected for study will yield products that achieve regulatory approval by the Food & Drug Administration (FDA). To help stakeholders navigate this complex market, MarketResearch.com offers a suite of comprehensive drug discovery reports on industries big and small.
Understanding the Drug Discovery Market
- Our compilation of reports features thousands of reports from leading research firms, allowing you to access highly targeted information.
- We provide a rich repository of data, including analysis of drug discovery market trends, forecasts, growth opportunities, and strategies.
- We also provide expert commentary on disruptive technologies and the use of artificial intelligence, machine learning, and blockchain in drug discovery.
Informed Insights: Your Path to Success
Whether you're an industry professional, a consultant, or an executive, our research collection provides credible data to help you make informed decisions that catalyze growth. For decades, we have served top pharmaceutical companies, investment banks, and consulting firms as a trusted research partner. Uncover new opportunities and stay ahead of the curve with MarketResearch.com's drug discovery industry reports.
Drug Discovery Industry Research & Market Reports
-
Gastrointestinal Drugs Global Market Briefing 2023
... market was $9.7 and in terms of global GDP, the market was 0.07%. Gastrointestinal drugs was the eighth largest segment within the market accounting for 4.7% preceded and followed by metabolic disorders drugs at 5.7% ... Read More
-
Musculoskeletal Disorders Drugs Global Market Briefing 2023
... consumption, the market was $13.4 and in terms of global GDP, the market was 0.09%. Musculoskeletal disorders drugs was the sixth largest segment within the market accounting for 6.5% preceded and followed by cardiovascular drugs ... Read More
-
Crohn'S Disease Diagnostics and Therapeutics Market - Growth, Trends, Covid-19 Impact, and Forecasts (2023 - 2028)
... With the rise in COVID-19, the prevalence of other related complications also increased. According to a report by the SECURE-IBD database in January 2022, adverse COVID-19 outcomes were associated with age and other co-morbidities among ... Read More
-
Clinical Trial Management Systems Market - Growth, Trends, Covid-19 Impact, and Forecasts (2023 - 2028)
... COVID-19 pandemic affected the clinical research activities as a large number of clinical studies on other diseases around the world were disrupted by the pandemic and the companies shifted their focus to the development of ... Read More
-
Europe Clinical Trials Market - Growth, Trends, Covid-19 Impact, and Forecasts (2023 - 2028)
... and the increasing prevalence of diseases. Key Highlights Another driving factor is the increasing focus on rare diseases and multiple orphan drugs in the pipeline. As rare diseases have considerably low prevalence rate, as compared ... Read More
-
Inflammatory Bowel Disease (Ibd) Therapeutics Market- Growth, Trends, Covid-19 Impact, and Forecasts (2023 - 2028)
... the rise of COVID 19, there has been a rise in other complications that arise along with the infection. According to a report by Surveillance Epidemiology of Coronavirus Under Research Exclusion (SECURE-IBD) database in January ... Read More
-
Australia Pharmaceuticals Market - Growth, Trends, Covid-19 Impact, and Forecasts (2023 - 2028)
... had shifted their focus toward R&D departments to identify new molecules or leads for the treatment of this disease, which is in the final phase of clinical trials. In January 2021, the Therapeutic Goods and ... Read More
-
Multiple Sclerosis Therapeutics Market - Growth, Trends, Covid-19 Impact, and Forecasts (2023 - 2028)
... 5.38% during the forecast period (2022-2027). COVID-19 has become a big concern for medical professionals across the board. Patients with multiple sclerosis (MS), commonly on immunosuppressive medicines, have expressed concern about the higher mortality rate ... Read More
-
Denmark Pharmaceutical Market - Growth, Trends, Covid-19 Impact, and Forecasts (2023 - 2028)
... biotech companies are concentrating their research & development departments on finding new compounds or leads for the treatment of this disease, which is in the last stages of clinical trials, as a result of the ... Read More
-
Middle East and Africa (Mea) Kidney Cancer Therapeutics & Diagnostics Market - Growth, Trends, Covid-19 Impact, and Forecasts (2023 - 2028)
... to grow with a CAGR of 5.2% over the forecast period. The market will show rapid growth due to the rising number of kidney cancer cases in the region and the increasing R&D expenditure of ... Read More
-
Osteoarthritis Treatment Market - Growth, Trends, Covid-19 Impact, and Forecasts (2023 - 2028)
... to show a short-term impact on the market growth as it had led to the cancelation or postponement of the scheduled treatment procedures along with a decrease in the number of new diagnoses and treatment ... Read More
-
Leunited Kingdomemia Therapeutics Market - Growth, Trends, Covid-19 Impact, and Forecasts (2023 - 2028)
... treatments were deferred due to the outbreak of the COVID-19 pandemic, the hematologic malignancies treatment was also impacted significantly. However, delayed treatment is not recommended for severe diseases, especially acute leUnited Kingdomemia, and thus, necessary ... Read More
-
Gastrointestinal Therapeutics Market - Growth, Trends, Covid-19 Impact, and Forecasts (2023 - 2028)
... disruption of supply chains, and the healthcare sector was affected badly. But the gastrointestinal therapeutics market showed a stable growth due to the correlation between Covid-19 and Gastrointestinal (GI) patients. A research study “COVID-19 and ... Read More
-
Social Anxiety Disorder (SAD) - Drug Pipeline Landscape, 2023
... environmental factors like inherited traits, brain structure (amygdala may play a role in controlling the fear response), and environment. The main symptoms of social anxiety disorders are a person's inability to work, difficulty maintaining friendships, ... Read More
-
Transcriptomics Market by Type (Instruments, Consumables, Software, Services), Technology (Microarray, Real-Time Quantitative Polymerase Chain Reaction (Q-PCR), Sequencing Technologies), Application (Diagnostics and Disease Profiling, Drug Discovery, and
... Biotechnology Companies, and Others), and Region 2023-2028 The global transcriptomics market size reached US$ 6.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 10.54 Billion by 2028, exhibiting a growth ... Read More
-
Amyotrophic Lateral Sclerosis Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... market to reach US$ 969.3 Million by 2028, exhibiting a growth rate (CAGR) of 4.9% during 2023-2028. Amyotrophic Lateral Sclerosis (ALS) Treatment refers to a degenerative disease that affects the nerve cells in the spinal ... Read More
-
Peptic Ulcer Drugs Market by Product (Proton Pump Inhibitors, Potassium-Competitive Acid Blocker (P-CAB)), Antacids, H2-Antagonists, Antibiotics, Ulcer protective), Ulcer Type (Gastric Ulcer, Duodenal Ulcer, and Others), Distribution Channel (Hospital Pha
... Region 2023-2028 The global peptic ulcer drugs market size reached US$ 4.63 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 5.96 Billion by 2028, exhibiting a growth rate (CAGR) of ... Read More
-
Epilepsy Drugs Market by Generation Type (First Generation Drugs, Second Generation Drugs, Third Generation Drugs), Anti-Epileptics Drugs Type (Narrow-Spectrum AEDs, Broad-Spectrum AEDs), Distribution Channel (Hospital Pharmacy, Pharmacy Stores, and Other
... epilepsy drugs market size reached US$ 2.16 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 3.52 Billion by 2028, exhibiting a growth rate (CAGR) of 8.2% during 2023-2028. The rising ... Read More
-
Mucopolysaccharidosis - Drug Pipeline Landscape, 2023
... types of mucopolysaccharidosis : mps type I (hurler syndrome), mps type II (hunter syndrome), mps type III (sanfilippo syndrome), mps type IV (morquio syndrome), mps type VI (maroteaux-lamy syndrome), mps type VII (sly syndrome), and ... Read More
-
Fabry Disease Market by Type (Type 1, Type 2, and Others), Diagnosis and Treatment (Diagnosis, Treatment), End User (Hospitals, Homecare, Specialty Clinics, and Others), and Region 2023-2028
... 1.88 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 2.88 Billion by 2028, exhibiting a growth rate (CAGR) of 7.26% during 2023-2028. The increasing number of patients suffering from fabry ... Read More
-
North American URTI Market 2022-2028
... Group >18 to 400 Years, Age Group >40 to 65 Years, and Age Group >65 Years) Forecast, 2022-2028 Market Overview Upper respiratory tract infection (URTI) is a medical illness caused by an acute infection in ... Read More
-
Alzheimer’s disease diagnostics and therapeutics Market, by Product (Therapeutics (Cholinesterase Inhibitors, NMDA Receptor Antagonists, Others) and Diagnostics (Brain Imaging, CSF Test for Alzheimer’s Disease)), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 Alzheimer’s disease is a neurodegenerative disease that usually starts slowly and progressively worsens. It is a progressive form of dementia, a continuous decline ... Read More
-
Global Hepatitis B Virus (HBV) Vaccine Market: Analysis By End User (Adult & Pediatric), By Composition (Mono & Combination), By Region (The US, China, EU+UK, Japan & ROW), Size and Trends with Impact of COVID-19 and Forecast up to 2027
... and Forecast up to 2027 The global hepatitis B virus (HBV) vaccine market was valued at US$2.23 billion in 2021, and is predicted to grow to US$3.04 billion in 2027. The hepatitis B virus (HBV) ... Read More
-
Europe Overactive Bladder Treatment Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Pharmacotherapy (Anticholinergics, Mirabegron, Botox, Neurostimulation, and Intravesical Instillation) and Disease Type (Idiopathic Overactive Bladder and Neurogenic Bladder)
... overactive bladder treatment market is expected to grow from US$ 1,111.05 million in 2022 to US$ 1,318.55 million by 2028; it is estimated to grow at a CAGR of 2.9% from 2022 to 2028. Growing ... Read More
-
Anticonvulsant Drugs Market, by Drug Class (Barbiturates, Benzodiazepines, Aromatic allylic alcohols, Carboxamides, Triazine, AMPA receptor antagonists, Carbamate, Hydantoin, Fatty Acid Derivative, GABA analogs, Valproylamides, Others (Propionates, Oxazolidinediones, etc.)), by Route of Administration (Enteral, Parenteral), by Indication (Epilepsy, Neuropathic pain, Anxiety, Fibromyalgia, Bipolar Disorder, Others (Borderline personality disorder, etc.)), by Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Indication (Epilepsy, Neuropathic pain, Anxiety, Fibromyalgia, Bipolar Disorder, Others (Borderline personality disorder, etc.)), by Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and ... Read More
Research Assistance
